Skip to main content

Advertisement

SpringerLink
Log in

Molecular basis for Epstein-Barr virus induced pathogenesis and disease

  • Concepts in Viral Biology
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Conclusion

In summary, information obtained from single gene transfer into EBV-negative cell lines is consistent with molecular genetic analysis of in vitro transformation by the whole virus in emphasizing the role for EBNA2 and LMP-1 in cell growth transformation. In addition, the functions of the latent infection proteins in tissue culture cells is consistent with the pathology of the EBV-associated lesions. The repertoire of viral proteins displayed in vivo varies with the different tissues infected and the differentiation state of infected cells, and is likely to reflect, in part, the activity of the latent infection promoters in these cells. Recent methods for obtaining specific virus mutants will enable more complete characterization of the EBV latent infection proteins and their roles in EBV-induced immortalization and pathogenesis [79].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alfieri C, Birkenbach M, Kieff E (1991) Early events in Epstein-Barr virus infection of human B-lymphocytes. Virology 181: 595.

    Google Scholar 

  2. Allday MJ, Crawford DH, Griffin BE (1989) Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol 70: 1755.

    Google Scholar 

  3. Ambinder RF, Mullen M, Chang Y-N, Hayward GS, Hayward SD (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 65: 1466.

    Google Scholar 

  4. Clarke PA, Sharp NA, Clemens MJ (1990) EBER-1 can prevent ds RNA-activated inhibition of protein synthesis in vitro. Eur J Biochem 193: 635.

    Google Scholar 

  5. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ, (1991) Binding of Epstein-Barr virus small nuclear RNA EBER-1 to the double stranded RNA-activated protein kinase DA1. Nucleic Acids Res 19: 243.

    Google Scholar 

  6. Cohen JI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70: 137.

    Google Scholar 

  7. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci, USA 86: 9558.

    Google Scholar 

  8. Cohen JI, Wang F, Kieff E (1991) Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 65: 2545.

    Google Scholar 

  9. Cooper NR, Moore MD, Nemerow GR (1988) Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement receptor. Annu Rev Immunol 6: 85.

    Google Scholar 

  10. Dambaugh T, Wang F, Hennessy K, Woodland E, Rickinson A, Kieff E (1986) Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J Virol 59: 453.

    Google Scholar 

  11. Dawson CW, Rickinson AB, Young LS (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344: 777.

    Google Scholar 

  12. DeCaprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275.

    Google Scholar 

  13. De Souza YG, Greenspan D, Felton JR, Hartzog GA, Hammer M, Greenspan JS (1989) Localization of Epstein-Barr virus DNA in the epithelial cells of oral hairy leukoplakia by in situ hybridization on tissue sections. N Engl J Med 320: 1559.

    Google Scholar 

  14. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934.

    Google Scholar 

  15. Fahraeus R, Fu H-L, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Wilson E, Yadav M, Busson P, Tursz T, Kallin B (1988) Expression of Epstein-Barr virus encoded proteins in Nasopharyngeal Carcinoma. Int J Cancer 42: 329.

    Google Scholar 

  16. Falk K, Ernberg I, Sakthivel R, Davis J, Christensson B, Luka J, Okano M, Grierson HL, Klein G, Purtillo DT (1990) Expression of Epstein-Barr virus-encoded proteins and B cell markers in fatal infectious mononucleosis. Int J Cancer 46: 976.

    Google Scholar 

  17. Friedman-Kien AE (1986) Viral origin of hairy leukoplakia. Lancet II: 694.

    Google Scholar 

  18. Furukawa Y, DeCaprio JA, Freedman A, Kanakura Y, Nakamura M, Ernst TJ, Livingston DM, Griffin JD (1990) Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci, USA 87: 2770.

    Google Scholar 

  19. Gilligan K, Sato H, Rajadurai P, Busson P, Young L, Rickinson A, Tursz T, Raab-Traub N (1990) Novel transcription from the Epstein-Barr virus terminal Eco RI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64: 4948.

    Google Scholar 

  20. Gilligan K, Rajaduri P, Resnick L, Raab-Traub N (1990) Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci, USA 87: 8790.

    Google Scholar 

  21. Gordon J, Walker L, Guy G, Rowe M, Rickinson A (1986) Control of human B-lymphocyte replication: transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology 58: 591.

    Google Scholar 

  22. Gratama JW, Zotter MM, Minarovits J, Oosterveer MAP, Thomas ED, Klein G, and Ernberg I (1991) Expression of EBV-encoded rowth-transformation associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 47: 188.

    Google Scholar 

  23. Greenspan JS, Greenspan D, Lennette ET (1985) Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N Engl J Med 985: 1564.

    Google Scholar 

  24. Gregory CD, Tursz T, Edwards CE, Tetaud C, Talbot M, Caillou B, Rickinson A, Lipinski M (1987) Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol 139: 313.

    Google Scholar 

  25. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612.

    Google Scholar 

  26. Hammerschmidt W, Sugden B (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393.

    Google Scholar 

  27. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107.

    Google Scholar 

  28. Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Strauss SE (1987) Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84: 570.

    Google Scholar 

  29. Hitt MM, Allday MJ, Hara T, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE (1989) EBV gene expression in an NPC-related tumour. EMBO J 8: 2639.

    Google Scholar 

  30. Howe JG, Steitz JA (1986) Localization of the Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83: 9006.

    Google Scholar 

  31. Joab I, Rowe D, Bodescot M, Nicolas J, Farrell P, Perricaudet M (1987) Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector. J Virol 61: 3340.

    Google Scholar 

  32. Kallin B, Dillner J, Ernberg I, Ehlin-Henriksson B, Rosen A, Henle W, Henle G, Klein G (1986) Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci 83: 1499.

    Google Scholar 

  33. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the cmyc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603.

    Google Scholar 

  34. Klein G (1979) The relationship of the virus to nasopharyngeal carcinoma. In: Epstein MA, Achong BC (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 340–350.

    Google Scholar 

  35. Knutson J (1990) The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B cell immortalization. J Virol 64: 2530.

    Google Scholar 

  36. Lacy J, Summers WP, Watson M, Glazer PM, Summers WC (1987) Amplification and deregulation of myc following Epstein-Barr virus infection of a human B-cell line. Proc Natl Acad Sci USA 84: 5838.

    Google Scholar 

  37. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78: 805.

    Google Scholar 

  38. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211: 400.

    Google Scholar 

  39. Liebowitz D, Wang D, Kieff E (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 58: 233.

    Google Scholar 

  40. Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E (1987) An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol Cell Biol 7: 2299.

    Google Scholar 

  41. Longnecker R, Kieff E (1990) A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 64: 2319.

    Google Scholar 

  42. Longnecker R, Druker B, Roberts TM, Kieff E (1991) An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol 65: 3681.

    Google Scholar 

  43. Martin J, Sugden B (1991) Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol 65: 3246.

    Google Scholar 

  44. Moss DJ, Sculley TB, Pope JM (1986) Induction of Epstein-Barr virus nuclear antigens. J Virol 58: 988.

    Google Scholar 

  45. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099.

    Google Scholar 

  46. Murray R, Kurilla M, Griffin H, Brooks J, Mackett M, Arrand J, Rowe M, Burrows S, Moss D, Kieff E, Rickinson A (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87: 2906.

    Google Scholar 

  47. Palleson G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320.

    Google Scholar 

  48. Petti L, Sample C, Kieff E (1990) Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176: 563.

    Google Scholar 

  49. Rabbitts TH (1985) The c-myc proto-oncogene: involvement in chromosomal abnormalities. Trends Genet 1: 327.

    Google Scholar 

  50. Rabson ML, Gradiville L, Heston L, Miller G (1982) Nonimmortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol 44: 834.

    Google Scholar 

  51. Rawlins DR, Milman G, Hayward SD, Hayward GS (1985) Sequence-specific binding of the Epstein-Barr virus nuclear antigen (EBNA1) to clustered sites in the plasmid maintenance region. Cell 42: 659.

    Google Scholar 

  52. Reisman D, Sugden B (1986) Trans activation of the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 6: 3838.

    Google Scholar 

  53. Reisman D, Yates J, Sugden B (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 5: 1822.

    Google Scholar 

  54. Rickinson A, Young L, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus transformed B cells. J Virol 61: 1310.

    Google Scholar 

  55. Rooney C, Howe JG, Speck SH, Miller G (1989) Influences of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J Virol 63: 1531.

    Google Scholar 

  56. Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus encoded ribonucleic acids and the adenovirus associated ribonucleic acids VA1 and VA2. Mol Cell Biol 1: 785.

    Google Scholar 

  57. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt lymphoma cells. EMBO J 6: 2743.

    Google Scholar 

  58. Rowe M, Finke J, Szigeti R, Klein G (1988) Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. J Gen Virol 69: 1217.

    Google Scholar 

  59. Sample J, Kieff E (1990) Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes. J Virol 64: 1667.

    Google Scholar 

  60. Sample J, Hummel M, Braun D, Birkenbach M, Kieff E (1986) Nucleotide sequences of messenger RNAs encoding Epstein-Barr virus nuclear proteins reveals a probable transcriptional initiation site. Proc Natl Acad Sci USA 83: 5096.

    Google Scholar 

  61. Sample J, Liebowitz D, Kieff E (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63: 933.

    Google Scholar 

  62. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 88: 6343.

    Google Scholar 

  63. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310: 1225.

    Google Scholar 

  64. Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rickinson AB (1987) Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol 68: 805.

    Google Scholar 

  65. Sixbey JW, Shirley P, Israele V (1986) Detection of a transformation-incompetent Epstein-Barr virus genotype in a seronegative host. In: Ablashi DV, Faggioni A, Krueger GRF, Pagano JS, Pearson GR (eds) Epstein-Barr virus and human disease. Humana Press, New Jersey, pp 131–134.

    Google Scholar 

  66. Sixbey JW, Shirley P, Sloas M, Raab-Traub N, Israele V (1991) A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. J Infect Dis 163: 1008.

    Google Scholar 

  67. Sung NS, Kenney S, Gutsch D, Pagano JS (1991) EBNA-2 transactivates a lymphoid specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol 65: 2164.

    Google Scholar 

  68. Swaminathan S, Thompkinson B, Kieff E (1991) Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci, USA 88: 1546.

    Google Scholar 

  69. Thomas JA, Crawford DH (1989) Epstein-Barr virus associated B cell lymphomas in AIDS and after organ transplantation. Lancet I: 1075.

    Google Scholar 

  70. Thorley-Lawson DA, Mann KP (1985) Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med 162: 45.

    Google Scholar 

  71. Toczyski DPW, Steitz JA (1991) EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J 10: 459.

    Google Scholar 

  72. Walker L, Guy G, Brown G, Rowe M, Milner AE, Gordon J (1986) Control of human Blymphocyte replication: characterization of novel activation states that precede the entry of G. B cells into cycle. Immunology 58: 583.

    Google Scholar 

  73. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831.

    Google Scholar 

  74. Wang D, Liebowitz D, Kieff E (1988) The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J Virol 62: 2337.

    Google Scholar 

  75. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E (1988) Epstein-Barr virus latent infection membrane protein alters the human B lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 62: 4173.

    Google Scholar 

  76. Wang F, Petti L, Braun D, Sung S, Kieff E (1989) A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol 61: 945.

    Google Scholar 

  77. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64: 2309.

    Google Scholar 

  78. Wang F, Tsang S-F, Kurilla M, Cohen JI, Kieff E (1990) Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64: 3407.

    Google Scholar 

  79. Wang F, Marchini A, Kieff E (1991) Epstein-Barr virus (EBV) recombinants: use of a positive selection markers to rescue mutants in EBV-negative B-lymphoma cells. J Virol 65: 1701.

    Google Scholar 

  80. Wang F, Kikutani H, Tsang S-F, Kishimoto T, Kieff E (1991) Epstein-Barr virus nuclear antigen 2 transactivates a cis-acting CD23 DNA element. J Virol 65: 4101.

    Google Scholar 

  81. Wennborg A, Aman P, Saranath D, Pear W, Sumegi J, Klein G (1987) Conversion of lymphoma line (BJAB) by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased cmyc mRNA levels. Int J Cancer 40: 202.

    Google Scholar 

  82. Whyte P, Williamson NM, Harlow E (1989) Cellular targets for transformation by the adenovirus E1A proteins. Cell 56: 67.

    Google Scholar 

  83. Wilson JB, Weinberg W, Johnson R, Yupsa S, Levine AJ (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of Keratin 6. Cell 61: 1315.

    Google Scholar 

  84. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81: 3806.

    Google Scholar 

  85. Yokata A, Kikutani H, Tanaka T, Sato R, Barsumian EL, Suemura M, Kishimoto T (1988) Two species of human FcE receptor II (FcERII/CD23): tissue specific and IL4 specific regulation of gene expression. Cell 55: 611.

    Google Scholar 

  86. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69: 1051.

    Google Scholar 

  87. Young LS, Finerty S, Brooks L, Scullion F, Rickinson AB, Morgan AJ (1989) Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins. J Virol 63: 1967.

    Google Scholar 

  88. Young LS, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321: 1080.

    Google Scholar 

  89. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB, Farrell PJ (1991) Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65: 2868.

    Google Scholar 

  90. ZimberStrobl U, Suentzenich K-O, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir GM, Bornkamm GW (1991) Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol 65: 415.

    Google Scholar 

Download references

Author information

Author notes

  1. Clare Sample

    Present address: Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, 332 North Lauderdale, 38101, Memphis, TN, USA

Authors and Affiliations

  1. Departments of Medicine and Microbiology and Molecular Genetics, Harvard Medical School, 75 Francis Street, 02115, Boston, MA, USA

    Clare Sample & Elliott Kieff

Authors
  1. Clare Sample
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elliott Kieff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sample, C., Kieff, E. Molecular basis for Epstein-Barr virus induced pathogenesis and disease. Springer Semin Immunopathol 13, 133–146 (1991). https://doi.org/10.1007/BF00201464

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201464

Keywords

Search

Navigation